McMahon RP - Search Results

1

Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia.

Warren KR, Ball MP, Feldman S, Liu F, McMahon RP, Kelly DL. Warren KR, et al. Among authors: mcmahon rp. Biol Res Nurs. 2011 Oct;13(4):383-90. doi: 10.1177/1099800410393272. Epub 2010 Dec 30. Biol Res Nurs. 2011. PMID: 21196420 Free PMC article.

2

Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.

Ball MP, Warren KR, Feldman S, McMahon RP, Kelly DL, Buchanan RW. Ball MP, et al. Among authors: mcmahon rp. Clin Schizophr Relat Psychoses. 2011 Apr;5(1):17-25. doi: 10.3371/CSRP.5.1.3. Clin Schizophr Relat Psychoses. 2011. PMID: 21459735 Clinical Trial.

3

Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia.

Koola MM, Boggs DL, Kelly DL, Liu F, Linthicum JA, Turner HE, McMahon RP, Gorelick DA. Koola MM, et al. Among authors: mcmahon rp. Psychiatry Res. 2013 Oct 30;209(3):273-8. doi: 10.1016/j.psychres.2013.07.044. Epub 2013 Aug 20. Psychiatry Res. 2013. PMID: 23969281 Free PMC article.

4

Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study.

Kelly DL, Weiner E, Ball MP, McMahon RP, Carpenter WT, Buchanan RW. Kelly DL, et al. Among authors: mcmahon rp. J Psychopharmacol. 2009 Jun;23(4):436-41. doi: 10.1177/0269881108093883. Epub 2008 Jun 26. J Psychopharmacol. 2009. PMID: 18583442 Free PMC article. Clinical Trial.

5

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM. Kelly DL, et al. Among authors: mcmahon rp. Psychiatr Q. 2006 Spring;77(1):81-95. doi: 10.1007/s11126-006-7963-9. Psychiatr Q. 2006. PMID: 16397757

6

Galantamine for the treatment of cognitive impairments in people with schizophrenia.

Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM, McMahon RP. Buchanan RW, et al. Among authors: mcmahon rp. Am J Psychiatry. 2008 Jan;165(1):82-9. doi: 10.1176/appi.ajp.2007.07050724. Epub 2007 Nov 6. Am J Psychiatry. 2008. PMID: 17986678 Clinical Trial.

7

Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.

McMahon RP, Kelly DL, Boggs DL, Li L, Hu Q, Davis JM, Carpenter WT Jr. McMahon RP, et al. Schizophr Bull. 2008 Mar;34(2):292-301. doi: 10.1093/schbul/sbm152. Epub 2008 Jan 8. Schizophr Bull. 2008. PMID: 18184634 Free PMC article.

8

The effects of galantamine on psychopathology in chronic stable schizophrenia.

Conley RR, Boggs DL, Kelly DL, McMahon RP, Dickinson D, Feldman S, Ball MP, Buchanan RW. Conley RR, et al. Among authors: mcmahon rp. Clin Neuropharmacol. 2009 Mar-Apr;32(2):69-74. doi: 10.1097/WNF.0B013E31816F2795. Clin Neuropharmacol. 2009. PMID: 18978489 Free PMC article. Clinical Trial.

9

Kelly DL, Wehring HJ, Linthicum J, Feldman S, McMahon RP, Love RC, Wagner T, Shim JC, Fowler DR. Kelly DL, et al. Among authors: mcmahon rp. Schizophr Res. 2009 Feb;107(2-3):134-8. doi: 10.1016/j.schres.2008.10.020. Epub 2008 Nov 22. Schizophr Res. 2009. PMID: 19028422 Free PMC article.

10

A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.

Kelly DL, Buchanan RW, Boggs DL, McMahon RP, Dickinson D, Nelson M, Gold JM, Ball MP, Feldman S, Liu F, Conley RR. Kelly DL, et al. Among authors: mcmahon rp. J Clin Psychiatry. 2009 Apr;70(4):518-25. doi: 10.4088/jcp.08m04358. Epub 2009 Apr 7. J Clin Psychiatry. 2009. PMID: 19358788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters